• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症的发病机制:着重于分子途径及天然疗法的预防作用

Pathogenesis of Huntington's Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies.

作者信息

Irfan Zainab, Khanam Sofia, Karmakar Varnita, Firdous Sayeed Mohammed, El Khier Bothaina Samih Ismail Abou, Khan Ilyas, Rehman Muneeb U, Khan Andleeb

机构信息

Department of Pharmaceutical Technology, Brainware University, Kolkata 700125, West Bengal, India.

Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology & AHS, Howrah 711316, West Bengal, India.

出版信息

Brain Sci. 2022 Oct 14;12(10):1389. doi: 10.3390/brainsci12101389.

DOI:10.3390/brainsci12101389
PMID:36291322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9599635/
Abstract

BACKGROUND

Huntington's disease is an inherited autosomal dominant trait neuro-degenerative disorder caused by changes (mutations) of a gene called huntingtin () that is located on the short arm (p) of chromosome 4, CAG expansion mutation. It is characterized by unusual movements, cognitive and psychiatric disorders.

OBJECTIVE

This review was undertaken to apprehend biological pathways of Huntington's disease (HD) pathogenesis and its management by nature-derived products. Natural products can be lucrative for the management of HD as it shows protection against HD in pre-clinical trials. Advanced research is still required to assess the therapeutic effectiveness of the known organic products and their isolated compounds in HD experimental models.

SUMMARY

Degeneration of neurons in Huntington's disease is distinguished by progressive loss of motor coordination and muscle function. This is due to the expansion of CAG trinucleotide in the first exon of the gene responsible for neuronal death and neuronal network degeneration in the brain. It is believed that the factors such as molecular genetics, oxidative stress, excitotoxicity, mitochondrial dysfunction, neuroglia dysfunction, protein aggregation, and altered UPS leads to HD. The defensive effect of the natural product provides therapeutic efficacy against HD. Recent reports on natural drugs have enlightened the protective role against HD via antioxidant, anti-inflammatory, antiapoptotic, and neurofunctional regulation.

摘要

背景

亨廷顿舞蹈症是一种常染色体显性遗传的神经退行性疾病,由位于4号染色体短臂(p)上的亨廷顿基因(HTT)发生变化(突变),即CAG重复序列扩增突变引起。其特征为异常运动、认知和精神障碍。

目的

本综述旨在了解亨廷顿舞蹈症(HD)发病机制的生物学途径及其天然产物治疗方法。天然产物对HD的治疗可能有益,因为在临床前试验中显示出对HD的保护作用。仍需进一步研究来评估已知有机产物及其分离化合物在HD实验模型中的治疗效果。

总结

亨廷顿舞蹈症中神经元的退化表现为运动协调和肌肉功能的逐渐丧失。这是由于负责神经元死亡和大脑神经网络退化的HTT基因第一外显子中CAG三核苷酸的扩增。据信,分子遗传学、氧化应激、兴奋性毒性、线粒体功能障碍、神经胶质细胞功能障碍、蛋白质聚集和UPS改变等因素会导致HD。天然产物的保护作用为HD提供了治疗效果。最近关于天然药物的报道揭示了其通过抗氧化、抗炎、抗凋亡和神经功能调节对HD的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/e13db37335a1/brainsci-12-01389-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/b7f276717475/brainsci-12-01389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/df33729edee8/brainsci-12-01389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/81732f2ef374/brainsci-12-01389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/419adfdbf2a8/brainsci-12-01389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/2694ccfc24be/brainsci-12-01389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/e13db37335a1/brainsci-12-01389-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/b7f276717475/brainsci-12-01389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/df33729edee8/brainsci-12-01389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/81732f2ef374/brainsci-12-01389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/419adfdbf2a8/brainsci-12-01389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/2694ccfc24be/brainsci-12-01389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/9599635/e13db37335a1/brainsci-12-01389-g006.jpg

相似文献

1
Pathogenesis of Huntington's Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies.亨廷顿舞蹈症的发病机制:着重于分子途径及天然疗法的预防作用
Brain Sci. 2022 Oct 14;12(10):1389. doi: 10.3390/brainsci12101389.
2
Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.下调与突触功能相关的神经胶质基因可减轻亨廷顿病的发病机制。
Elife. 2021 Apr 19;10:e64564. doi: 10.7554/eLife.64564.
3
Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease.旨在全面理解线粒体功能障碍和氧化应激在亨廷顿病发病机制和病理生理学中的作用。
J Neurosci Res. 2019 Nov;97(11):1455-1468. doi: 10.1002/jnr.24492. Epub 2019 Jul 15.
4
Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.亨廷顿病相关行为、细胞和病理特征的促进:亨廷顿病基因缺失在神经节内侧和外侧谱系中差异破坏区域中间神经元和投射神经元亚型。
J Neurosci. 2019 Mar 6;39(10):1892-1909. doi: 10.1523/JNEUROSCI.2443-18.2018. Epub 2019 Jan 9.
5
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.亨廷顿病猴诱导多能干细胞源性神经祖细胞衍生的星形胶质细胞改善亨廷顿病表型。
PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019.
6
Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in .雷帕霉素可减少神经元中突变型亨廷顿蛋白的聚集,并改善其运动能力。
Front Aging Neurosci. 2023 Sep 26;15:1223911. doi: 10.3389/fnagi.2023.1223911. eCollection 2023.
7
Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.亨廷顿病的多种临床特征与突变 HTT 基因 CAG 重复长度和神经退行性变相关。
J Neurol. 2019 Mar;266(3):551-564. doi: 10.1007/s00415-018-8940-6. Epub 2018 Jun 28.
8
Huntington's Disease and Mitochondria.亨廷顿病与线粒体。
Neurotox Res. 2017 Oct;32(3):518-529. doi: 10.1007/s12640-017-9766-1. Epub 2017 Jun 21.
9
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington's Disease.治疗亨廷顿舞蹈病的天然小分子治疗药物的新兴领域。
Curr Neuropharmacol. 2023;21(4):867-889. doi: 10.2174/1570159X21666230216104621.
10
Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington's Disease Models.七叶亭对亨廷顿病模型中突变型亨廷顿蛋白诱导的毒性具有神经保护作用。
Pharmaceuticals (Basel). 2021 Oct 13;14(10):1044. doi: 10.3390/ph14101044.

引用本文的文献

1
Natural products proposed for the management of Huntington's disease (HD): a comprehensive review.用于治疗亨廷顿舞蹈症(HD)的天然产物:全面综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 17. doi: 10.1007/s00210-025-04444-w.
2
Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons.揭示钠钾ATP酶泵的作用:神经退行性机制与治疗前景
Pharmacol Rep. 2025 Jun;77(3):576-592. doi: 10.1007/s43440-025-00717-6. Epub 2025 Mar 21.
3
The Role of MicroRNAs in Neurodegeneration: Insights from Huntington's Disease.

本文引用的文献

1
Functional interplay between central and autonomic nervous systems in human fear conditioning.人类恐惧条件反射中中枢神经系统和自主神经系统的功能相互作用。
Trends Neurosci. 2022 Jul;45(7):504-506. doi: 10.1016/j.tins.2022.04.003. Epub 2022 May 13.
2
Myelinosome Organelles in the Retina of R6/1 Huntington Disease (HD) Mice: Ubiquitous Distribution and Possible Role in Disease Spreading.R6/1 亨廷顿病(HD)小鼠视网膜中的髓鞘小体细胞器:普遍分布及其在疾病传播中的可能作用。
Int J Mol Sci. 2021 Nov 25;22(23):12771. doi: 10.3390/ijms222312771.
3
Gene Therapy for Huntington's Disease: The Final Strategy for a Cure?
微小RNA在神经退行性变中的作用:来自亨廷顿舞蹈病的见解
Mol Neurobiol. 2025 Feb 26. doi: 10.1007/s12035-025-04750-7.
4
Diagnostic role of circulating cell-free DNA in schizophrenia and neuro-degenerative disorders.循环游离DNA在精神分裂症和神经退行性疾病中的诊断作用。
Biomark Med. 2025 Mar;19(5):165-176. doi: 10.1080/17520363.2025.2468151. Epub 2025 Feb 24.
5
The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases.聚合物纳米颗粒作为药物递送载体在神经退行性疾病细胞中的应用。
Cell Prolif. 2025 Aug;58(8):e13804. doi: 10.1111/cpr.13804. Epub 2025 Feb 11.
6
Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges.基于神经疾病多方面机制和特点的理想动物模型:现状与挑战
Arch Pharm Res. 2025 Jan;48(1):62-88. doi: 10.1007/s12272-024-01527-9. Epub 2024 Dec 18.
7
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS.解读神经退行性变:阿尔茨海默病、帕金森病和肌萎缩侧索硬化症的分子机制与治疗进展综述
Int J Mol Sci. 2024 Nov 24;25(23):12613. doi: 10.3390/ijms252312613.
8
Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases.高迁移率族蛋白B1信号在神经退行性疾病中的病理生理作用
Inflammopharmacology. 2025 Feb;33(2):703-727. doi: 10.1007/s10787-024-01595-9. Epub 2024 Nov 15.
9
Application of mesenchymal stem cells for neurodegenerative diseases therapy discovery.间充质干细胞在神经退行性疾病治疗探索中的应用。
Regen Ther. 2024 Oct 30;26:981-989. doi: 10.1016/j.reth.2024.09.014. eCollection 2024 Jun.
10
Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues.神经紊乱的表观遗传学探索、鉴定方法和治疗途径。
Int J Mol Sci. 2024 Oct 30;25(21):11658. doi: 10.3390/ijms252111658.
亨廷顿舞蹈症的基因治疗:治愈的最终策略?
J Mov Disord. 2022 Jan;15(1):15-20. doi: 10.14802/jmd.21006. Epub 2021 Nov 17.
4
Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway.慢性疼痛中的协同参与者:神经炎症与色氨酸-犬尿氨酸代谢途径
Biomedicines. 2021 Jul 26;9(8):897. doi: 10.3390/biomedicines9080897.
5
Monitoring the kynurenine system: Concentrations, ratios or what else?监测犬尿氨酸系统:浓度、比值还是其他什么?
Adv Clin Exp Med. 2021 Aug;30(8):775-778. doi: 10.17219/acem/139572.
6
Xyloketal B: A marine compound with medicinal potential.木榴醇 B:一种具有药用潜力的海洋化合物。
Pharmacol Ther. 2022 Feb;230:107963. doi: 10.1016/j.pharmthera.2021.107963. Epub 2021 Aug 8.
7
The prevalence of pain in Huntington's disease in a large worldwide cohort.亨廷顿病患者疼痛的普遍性:一项大型国际队列研究。
Parkinsonism Relat Disord. 2021 Aug;89:73-78. doi: 10.1016/j.parkreldis.2021.06.015. Epub 2021 Jun 19.
8
Pain in Parkinson's disease and the role of the subthalamic nucleus.帕金森病的疼痛及丘脑底核的作用。
Brain. 2021 Jun 22;144(5):1342-1350. doi: 10.1093/brain/awab001.
9
What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease.何时以及如何测量——亨廷顿病治疗中的外周生物标志物。
Int J Mol Sci. 2021 Feb 4;22(4):1561. doi: 10.3390/ijms22041561.
10
Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.天然产物对亨廷顿病的保护作用:科学证据概述及其作用机制的理解。
ACS Chem Neurosci. 2021 Feb 3;12(3):391-418. doi: 10.1021/acschemneuro.0c00824. Epub 2021 Jan 21.